Monday, Jun 24 2019 | Time 19:09 Hrs(IST)
image
  • Mujeeb 3/39 restricts Bangladesh at 262/7
  • Mizo CM pens letter to Aviation Minister Puri on "unrealistic high" air fares
  • Ruling BJD MLA Saroj Meher sent to judicial custody for forcing an Engineer to do sit ups in public
  • Give us an India where Hindus, Muslims, Sikhs & Christians live for each other: Azad
  • Kejriwal is working in view of upcoming Assy elections:Manoj Tiwari
  • Polling for Junagadh Municipal Corporation to be held on Jul 1
  • Action taken against 271 companies in last three yrs to safeguard investors: Finance Min
  • AICC dissolves all UP district committees, two member team to oversee preparation for bypolls
  • Forty two votes required to host 2026 Winter Olympic and Paralympic Games
  • US, S Arabia talk maritime security in the Gulf
  • NITI Aayog to release 2nd edition of Healthy States, Progressive India report
  • Bhatpara gradually limping back to normal
  • Judicious use of water can save India from future calamities: Jal Shakti Minister
  • FC meets K'taka economists; discusses infra gaps, democratic deficit
Business Economy


Glenmark Pharmaceuticals receives ANDA approval for Hydrocortisone Valerate Ointment USP, 0.2 pc

Glenmark Pharmaceuticals receives ANDA approval for Hydrocortisone Valerate Ointment USP, 0.2 pc

Mumbai, Dec 17(UNI) Pharma major Glenmark Pharma said that Glenmark Pharmaceuticals Inc., US has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Hydrocortisone Valerate Ointment USP, 0.2 pc, a generic version of Westcort Ointment, 0.2 pc, of Sun Pharmaceutical Industries, Inc.

Glenmark has been granted a competitive generic therapy (CGT) designation for Hydrocortisone Valerate Ointment USP, 0.2 pc, therefore, with this approval, Glenmark is eligible for 180 days of CGT exclusivity upon commercialisation, Glenmark said in a filing with BSE.

This is Glenmark's first granted CGT product approved by the FDA.

According to IQVIATM sales data for the 12 month period ending October 2018, the Westcort Ointment, 0.2 pc market 2 achieved annual sales of approximately USD11.1 million.

Glenmark's current portfolio consists of 145 products authorized for distribution in the U.S. marketplace and 55 ANDA's pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

UNI JS NV JW1412

More News

UAE's LuLu Group to explore investment opportunities in HP

24 Jun 2019 | 6:48 PM

Shimla, Jun 24 (UNI) Accepting Himachal Pradesh Chief Minister Jai Ram Thakur's invitation to explore investment opportunities in the state, United Arab Emirates based LuLu Group International has decided to send a team to traverse the areas of collaboration.

see more..

NITI Aayog to release 2nd edition of Healthy States, Progressive India report

24 Jun 2019 | 6:39 PM

New Delhi, Jun 24 (UNI) NITI Aayog will release the second edition of “Healthy States, Progressive India” report on Jun 25.

see more..

FC meets K'taka economists; discusses infra gaps, democratic deficit

24 Jun 2019 | 6:23 PM

New Delhi, Jun 24 (UNI) The 15th Finance Commission on Monday met the Karnataka officials and was apprised of large infrastructure gaps and widening democratic deficit.

see more..
Rupee rises by 20 paise against USD

Rupee rises by 20 paise against USD

24 Jun 2019 | 6:07 PM

Mumbai, Jun 24 (UNI) The Rupee on Monday appreciated by 20 paise to 69.35 against the US Dollar, on renewed selling of US Dollars by bankers and exporters, dealers at Forex Market informed.

see more..

Honor 20 offers 90 pc buy back guarantee in 90 days

24 Jun 2019 | 5:58 PM

New Delhi, Jun 24 (UNI) Smartphone Honor on Monday came up with first of its kind challenge, where it will offer up to 90 per cent buy back guarantee in 90 days on HONOR 20.

see more..
image